Article Information
History
- April 20, 2020.
Article Versions
- Version 1 (April 15, 2020 - 03:42).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Ziyun Shao1,†,
- Yongwen Feng2,3,†,
- Li Zhong4,†,
- Qifeng Xie5,†,
- Ming Lei6,†,
- Zheying Liu5,
- Conglin Wang5,
- Jingjing Ji5,
- Liu Huiheng7,
- Zhengtao Gu8,
- Zhongwei Hu6,*,
- Lei Su5,*,
- Ming Wu2,* and
- Zhifeng Liu5,9,*
- 1Department of Nephrology, General Hospital of Central Theater Command of PLA, Wuhan, 430070, China
- 2Department of Critical Care Medicine and Hospital Infection Prevention and Control, The Second People’s Hospital of Shenzhen & First Affiliated Hospital of Shenzhen University, Health Science Center, Shenzhen, 518035, China
- 3Department of Critical Care Medicine, The Third People’s Hospital of Shenzhen, Shenzhen, 518035, China
- 4Department of Critical Care Medicine, The First Affiliated Hospital, Guizhou University of Chinese Medicine, Guiyang, 550001, China
- 5Department of Critical Care Medicine, General Hospital of Southern Theater Command of PLA, Guangzhou, 510010, China
- 6Department of Nephrology, Guangzhou Eighth people’s hospital, Guangzhou Medical University, Guangzhou,510060, China
- 7Department of Emergency, Zhongshan Hospital of Xiamen University, Xiamen, 361000, China
- 8Department of Treatment Center for Traumatic Injuries, The Third Affiliated Hospital, Southern Medical University, Academy of Orthopedics Guangdong Province, Guangzhou, Guangdong, 515630, China
- 9Key Laboratory of Hot Zone Trauma Care and Tissue Repair of PLA, General Hospital of Southern Theater Command of PLA, Guangzhou, 510010, China
- ↵*To whom correspondence should be addressed: Dr. Zhifeng Liu, Department of Critical Care Medicine, General Hospital of Southern Theatre Command of PLA, Guangzhou, 510010, China. Fax: (86)20-3665-5909. Tel: (86)20-3665-3483; E-mail: Zhifengliu7797{at}163.com, Dr. Ming Wu, Department of Critical Care Medicine and Hospital Infection Prevention and Control, The Second People’s Hospital of Shenzhen & First Affiliated Hospital of Shenzhen University, Health Science Center, Shenzhen, 518035, China. Tel: (86)0755-8367-6149, E-mail: boshiyy{at}126.com, Prof. Lei Su, Department of Critical Care Medicine, General Hospital of Southern Theatre Command of PLA, Guangzhou, 510010. E-mail: slei_icu{at}163.com, Prof. Zhongwei Hu, Department of Nephrology, Guangzhou Eighth people’s hospital, Guangzhou Medical University, Guangzhou, 510060, China. E-mail: gz8hhzw{at}126.com
↵† These authors contributed equally to this work.
Posted April 20, 2020.
Clinical Efficacy of Intravenous Immunoglobulin Therapy in Critical Patients with COVID-19: A Multicenter Retrospective Cohort Study
